Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-27 @ 5:05 AM
Study NCT ID:
NCT00268450
Status:
TERMINATED
Last Update Posted:
2018-07-12
First Post:
2005-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery
Sponsor:
Medical University of South Carolina
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bladder Cancer | View |